期刊文献+

Intratracheal administration of recombinant adenovirus containing IL-18 gene in treatment of experimental metastatic lung carcinoma

Intratracheal administration of recombinant adenovirus containing IL-18 gene in treatment of experimental metastatic lung carcinoma
下载PDF
导出
摘要 Objective: To study the treatment of experimental metastatic lung carcinoma by intratracheal injection of IL-l8 gene recombinant adenovirus. Methods: (1)The mouse IL-18 mRNA was detected by RT-PCR, and the concentration of IL-18 and associated cytokines in lung lavages and blood were determined by ELISA at different time points after intratracheal injection of IL-18 recombinant adenovirus. (2)The lung metastasis nodes, mouse survival periods and survival rates were evaluated. NK activity and CTL activity were determined by 51Cr 4 h release method. Results: (1) IL-18 mRNA was detectable in lung tissue 6 h after intratracheal use of IL-18 recombinant adenovirus. and the concentration of IL-18 in lung lavage was higher than that in peripheral blood. Neither IL-18 mRNA nor IL-18 was detectable in control group. (2) Intratracheal use of IL-18 recombinant adenovirus resulted in increased CTL and NK activity, longer survival time and higher survival rates compared with the control group, showing significant therapeutic effect on expermental lung metastasis. Conclusion: Intratracheal use of adenovirus vector containing IL- 18 gene has therapeutic effect on the lung metastasis, denoting that gene therapy of lung diseases could be applied through airway directly with recombinant adenovirus. Objective: To study the treatment of experimental metastatic lung carcinoma by intratracheal injection of IL-l8 gene recombinant adenovirus. Methods: (1)The mouse IL-18 mRNA was detected by RT-PCR, and the concentration of IL-18 and associated cytokines in lung lavages and blood were determined by ELISA at different time points after intratracheal injection of IL-18 recombinant adenovirus. (2)The lung metastasis nodes, mouse survival periods and survival rates were evaluated. NK activity and CTL activity were determined by 51Cr 4 h release method. Results: (1) IL-18 mRNA was detectable in lung tissue 6 h after intratracheal use of IL-18 recombinant adenovirus. and the concentration of IL-18 in lung lavage was higher than that in peripheral blood. Neither IL-18 mRNA nor IL-18 was detectable in control group. (2) Intratracheal use of IL-18 recombinant adenovirus resulted in increased CTL and NK activity, longer survival time and higher survival rates compared with the control group, showing significant therapeutic effect on expermental lung metastasis. Conclusion: Intratracheal use of adenovirus vector containing IL- 18 gene has therapeutic effect on the lung metastasis, denoting that gene therapy of lung diseases could be applied through airway directly with recombinant adenovirus.
出处 《Journal of Medical Colleges of PLA(China)》 CAS 2001年第1期12-15,共4页 中国人民解放军军医大学学报(英文版)
基金 National Natural Science Foundation of China (No.39730420 )
关键词 重组腺病毒 IL-18 肺癌 试验 新陈代谢 基因治疗 recombinant adenovirus airway interleukin-18 experimental lung metastasis, gene therapy, immunotherapy
  • 相关文献

参考文献9

  • 1[1]Rosenfeld MA, Yoshimura K, Trapnell BG et al. In vivo transfer of the human cystic fiberosis transmembrane conductance regulator gene to the airway epithelium. Cell, 1992; 68( 1): 143
  • 2[2]Cao X, Zhang W, He L et al. Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity. J Immunol, 1998; 161 (11):6238
  • 3[3]Mcallef MJ, Yoshida K, Kawai S et al. In vivo antitumor effects of murine interferon-gamma-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites. Cancer Immunol Immunother, 1997; 57(20): 4557
  • 4[4]Osaki T, Peron JM,Cai Q et al. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects. J Immunol,1998; 160(4): 1742
  • 5[5]Fukumoto H, Nishio M, Nshio K et al. Interferon-gamma-inducing factor gene transfection into Lewis lung carcinoma cells reduces tumorigenicity in vivo. Jpn.JCancer Res, 1997; 88(5): 501
  • 6[6]Kong HL, Hecht D, Song W et al. Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a serected form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor. Human Gene Ther, 1998; 9(6): 823
  • 7[7]Tursz T, Cesne AL, Baldeyrou P et al. Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patients. J Natl Cancer Inst,1996; 88(24): 1857
  • 8[8]Xing Z, Braciak T, Jordan M et al. Adenovirus-mediates cytokine gene transfer at tissue sites. Overexpression of IL-6 induces lymphoytic hyperplasia in the lung. J Immunol, 1994; 153(9): 4059
  • 9[9]Kohno K, Kataoka J, Ohtsuki T et al. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its independently of IL-12. J Immunol, 1997: 158(4): 1541

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部